CAR-NK: Natural Born Cancer-Killers

CAR-NK: Natural Born Cancer-Killers

Further Down The Cancer Treatment Road With CARs Chimeric antigen receptor (CAR) T-cell therapies have captured the imagination of both scientists and the public. The ability to genetically alter a patient’s own cells to fight cancer has revolutionized the treatment...
Immune Checkpoint Inhibitors

Immune Checkpoint Inhibitors

A Killer(-T) Nobel Prize In Medicine On October 1, James Allison, now at the M.D. Anderson Cancer Center in Houston, and Tasuku Honjo, now at Kyoto University, won the 2018 Nobel Prize in Physiology or Medicine. The two scientists discovered the basis for today’s...
Immunotherapy Goes Viral

Immunotherapy Goes Viral

VIRUSES BLASTING CANCER   Last week, Johnson & Johnson (New Brunswick, NJ ) announced that their biotech arm Janssen Labs (Rariton, NJ) is investing up to $1 billion dollars to acquire BeneVir, a small biotech based in Rockville, Maryland, which focuses on...
Eye Of The Cytokine Storm

Eye Of The Cytokine Storm

THE FLASH OF THE FIRST CAR-T Last week’s much anticipated FDA approval of the first chimeric antigen receptor T-cell (CAR-T) therapy for acute lymphocytic leukemia hails as the first gene therapy on the US  market. Classified as a “cell-based gene therapy,” Novartis’...